Lineage Cell Therapeutics, Inc. (LCTX)
1.505
-0.08
(-4.75%)
USD |
NYAM |
Mar 18, 15:59
1.51
0.00 (0.00%)
After-Hours: 20:00
Lineage Cell Therapeutics Market Cap : 346.64M for March 18, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Pacira Biosciences, Inc. | 891.59M |
| OptimizeRx Corp. | 118.39M |
| Nutex Health, Inc. | 655.45M |
| ProKidney Corp. | 294.41M |
| Prime Medicine, Inc. | 637.35M |
Market Cap Related Metrics
| PS Ratio | 23.95 |
| PEG Ratio | -0.0291 |
| Price to Book Value | 7.781 |
| Price | 1.505 |
| Earnings Yield | -18.49% |
| PEGY Ratio | -0.0291 |